- Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
-
Sakanaka K, Itasaka S, Ishida Y, Fujii K, Horimatsu , Mizowaki T, Sakai Y, Hiraoka M
- KMID: 2401791
- Radiat Oncol J.
- 2017 Dec;35(4):368-379.
- doi: 10.3857/roj.2017.00227
PURPOSE: The purpose of this study was to explore the dosimetric difference between simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) and three-dimensional conformal radiotherapy (3DCRT), and the clinical outcomes of anal... -
- CITED
-
- Close
- SHARE
-
- Close
